Older articles »
|Prostate cancer and Alzheimer's patients to benefit from new 20-tonne MRI scanner|
Added: 19.02.2018 12:23 | 0 views | 0 comments
Patients with diseases including prostate cancer, Parkinson's and Alzheimer's will benefit from a 20-tonne MRI scanner being installed at a London hospital.
|New mutation linked to ovarian cancer can be passed down through dad|
Added: 15.02.2018 20:23 | 1 views | 0 comments
A newly identified mutation, passed down through the X-chromosome, is linked to earlier onset of ovarian cancer in women and prostate cancer in father and sons.
|Apalutamide delays progression of nonmetastatic, castration-resistant prostate cancer|
Added: 10.02.2018 20:24 | 4 views | 0 comments
A multi-institutional phase 3 trial found that treatment with an investigational androgen receptor inhibitor significantly delayed the development of metastasis in patients with prostate cancer that had become resistant to standard androgen-deprivation therapy.
|Two Prostate Cancer Drugs Delay Spread of the Disease by Two Years|
Added: 08.02.2018 16:10 | 2 views | 0 comments
The treatments could help hundreds of thousands of men worldwide stave off pain and chemotherapy, but researchers don’t yet know if they will extend lives.
|Versatile sensor against tumor initiating cells|
Added: 07.02.2018 17:23 | 0 views | 0 comments
Researchers have developed the first fluorescent sensor to visualize TICs. Functional in lung, central nervous system, melanoma, breast, renal, ovarian, colon, and prostate cancer cell cultures, this could become a useful tool for biopsy-free post-treatment assessment and anti-TIC drug development.
|Xtandi ‘delays prostate cancer spread’|
Added: 05.02.2018 17:32 | 0 views | 0 comments
Use of Xtandi in early stage prostate cancer on top of standard hormone therapy reduces the risk of disease spreading or death by 71 per cent compared with hormone therapy alone, US study results show.
|PSMA PET/CT clearly differentiates prostate cancer from benign tissue|
Added: 05.02.2018 17:25 | 0 views | 0 comments
Using nuclear medicine, researchers have found a way to accurately differentiate cancerous tissue from healthy tissue in prostate cancer patients. The research demonstrates that the maximum standardized uptake value (SUVmax) on 68Ga-PSMA PET/CT scans correlates with PSMA-expression in primary prostate cancer. By this means, researchers were able to generate an SUVmax cutoff for the differentiation of cancerous and benign prostate tissue.
|Berizzo ´recovering well´ from prostate cancer|
Added: 04.02.2018 15:59 | 0 views | 0 comments
Sevilla say that former coach Eduardo Berizzo’s recovery from prostate cancer is proceeding in a positive manner. It was confirmed in November that Berizzo had been diagnosed with the disease, the 48-year-old taking a break from his duties as he underwent successful surgery the following month. Berizzo returned to the Sevilla dugout but later in […]
|Prostate cancer deaths overtake female breast cancer deaths in UK|
Added: 02.02.2018 1:52 | 1 views | 0 comments
The number of men dying from prostate cancer in the UK has overtaken female breast cancer deaths, new research reveals.